Defining Optimal Immunotherapies for Type 1 Diabetes

Defining Optimal Immunotherapies for Type 1 Diabetes - Novartis Foundation Symposium

Hardback (13 Jun 2008)

Not available for sale

Includes delivery to the United States

Out of stock

This service is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Publisher's Synopsis

  • This book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D).
  • Brings together contributions from the leaders in the arena of clinical immunotherapy, not limited to the diabetes field exclusively, in order to delineate a road-map that would lead to future clinical trials.
  • The book integrates information from human and animal studies.
  • The book considers T1D within the broader context of autoimmune disease.
  • The format contains several discussions, which address specific questions and provides guidelines for future strategies and solutions for discovering a cure.

Book information

ISBN: 9780470723258
Publisher: Wiley
Imprint: John Wiley & Sons, Inc.
Pub date:
DEWEY: 616.46206
DEWEY edition: 22
Language: English
Number of pages: 212
Weight: 476g
Height: 235mm
Width: 158mm
Spine width: 15mm